SURGICAL ASSOCIATES: what changed
SURGICAL ASSOCIATES
Largest movements
- Deferred charges and accrued income -€5,699
no longer reported in 2025 (was €5,699)
- Tangible fixed assets +€4,454
up €4,454 (+64.8%), from €6,875 to €11,329
of which Plant, machinery and equipment: +€2,892
- Receivables within one year +€2,214
up €2,214 (+1,558%), from €142 to €2,356
- Cash -€1,326
down €1,326 (-5.0%), from €26,684 to €25,358
mainly Investment in fixed assets (net) (-€7,369) and Trade debts (-€3,004)
- Trade debts -€3,004
down €3,004 (-75.5%), from €3,980 to €976
- Tax, wage and social debts +€1,576
up €1,576 (+165%), from €956 to €2,532
- Profit (loss) carried forward +€1,071
up €1,071 (+6.5%), from €16,462 to €17,533
- Gross operating margin -€5,507
down €5,507 (-44.9%), from €12,268 to €6,761
- Depreciation -€688
down €688 (-19.1%), from €3,603 to €2,915
- Taxes +€620
up €620 (+64.8%), from €956 to €1,576
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €39,400 | €39,043 | -€357 | -0.9% |
| Fixed assets | 21/28 | €6,875 | €11,329 | +€4,454 | +64.8% |
| Tangible fixed assets | 22/27 | €6,875 | €11,329 | +€4,454 | +64.8% |
| Plant, machinery and equipment | 23 | €1,244 | €4,136 | +€2,892 | +232% |
| Furniture and vehicles | 24 | €5,631 | €7,193 | +€1,561 | +27.7% |
| Current assets | 29/58 | €32,525 | €27,714 | -€4,811 | -14.8% |
| Amounts receivable within one year | 40/41 | €142 | €2,356 | +€2,214 | +1,558% |
| Other amounts receivable | 41 | €142 | €2,356 | +€2,214 | +1,558% |
| Cash at bank and in hand | 54/58 | €26,684 | €25,358 | -€1,326 | -5.0% |
| Deferred charges and accrued income | 490/1 | €5,699 | - | -€5,699 | |
| Total equity and liabilities | 10/49 | €39,400 | €39,043 | -€357 | -0.9% |
| Equity | 10/15 | €34,464 | €35,535 | +€1,071 | +3.1% |
| Contributions | 10/11 | €600 | €600 | = | 0.0% |
| Capital | 10 | €600 | €600 | = | 0.0% |
| Issued capital | 100 | €600 | €600 | = | 0.0% |
| Reserves | 13 | €17,402 | €17,402 | = | 0.0% |
| Non-distributable reserves | 130/1 | €7,437 | €7,437 | = | 0.0% |
| Legal reserve | 130 | €7,437 | €7,437 | = | 0.0% |
| Tax-exempt reserves | 132 | €9,966 | €9,966 | = | 0.0% |
| Profit (loss) carried forward | 14 | €16,462 | €17,533 | +€1,071 | +6.5% |
| Amounts payable | 17/49 | €4,936 | €3,508 | -€1,428 | -28.9% |
| Amounts payable within one year | 42/48 | €4,936 | €3,508 | -€1,428 | -28.9% |
| Trade debts | 44 | €3,980 | €976 | -€3,004 | -75.5% |
| Suppliers | 440/4 | €3,980 | €976 | -€3,004 | -75.5% |
| Taxes, remuneration and social security | 45 | €956 | €2,532 | +€1,576 | +165% |
| Taxes | 450/3 | €956 | €2,532 | +€1,576 | +165% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,603 | €2,915 | -€688 | -19.1% |
| Other operating charges | 640/8 | €981 | €1,032 | +€51 | +5.2% |
| Gross operating margin | 9900 | €12,268 | €6,761 | -€5,507 | -44.9% |
| Operating profit (loss) | 9901 | €7,684 | €2,814 | -€4,870 | -63.4% |
| Financial charges | 65/66B | €135 | €167 | +€32 | +23.4% |
| Recurring financial charges | 65 | €135 | €167 | +€32 | +23.4% |
| Profit (loss) for the period before taxes | 9903 | €7,549 | €2,647 | -€4,902 | -64.9% |
| Income taxes | 67/77 | €956 | €1,576 | +€620 | +64.8% |
| Profit (loss) for the period | 9904 | €6,592 | €1,071 | -€5,522 | -83.8% |
| Profit (loss) for the period to be appropriated | 9905 | €6,592 | €1,071 | -€5,522 | -83.8% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.